1. Home
  2. PLBC vs GNFT Comparison

PLBC vs GNFT Comparison

Compare PLBC & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLBC
  • GNFT
  • Stock Information
  • Founded
  • PLBC 1980
  • GNFT 1999
  • Country
  • PLBC United States
  • GNFT France
  • Employees
  • PLBC N/A
  • GNFT N/A
  • Industry
  • PLBC Finance Companies
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PLBC Finance
  • GNFT Health Care
  • Exchange
  • PLBC Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • PLBC 253.9M
  • GNFT 189.6M
  • IPO Year
  • PLBC 2005
  • GNFT 2019
  • Fundamental
  • Price
  • PLBC $48.65
  • GNFT $3.80
  • Analyst Decision
  • PLBC Buy
  • GNFT Strong Buy
  • Analyst Count
  • PLBC 2
  • GNFT 1
  • Target Price
  • PLBC $52.50
  • GNFT $13.00
  • AVG Volume (30 Days)
  • PLBC 10.6K
  • GNFT 9.8K
  • Earning Date
  • PLBC 01-15-2025
  • GNFT 09-19-2024
  • Dividend Yield
  • PLBC 2.22%
  • GNFT N/A
  • EPS Growth
  • PLBC N/A
  • GNFT N/A
  • EPS
  • PLBC 4.77
  • GNFT 0.47
  • Revenue
  • PLBC $79,873,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • PLBC N/A
  • GNFT $155.44
  • Revenue Next Year
  • PLBC $15.50
  • GNFT N/A
  • P/E Ratio
  • PLBC $10.20
  • GNFT $7.53
  • Revenue Growth
  • PLBC 3.64
  • GNFT 175.45
  • 52 Week Low
  • PLBC $32.50
  • GNFT $3.31
  • 52 Week High
  • PLBC $51.33
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • PLBC 55.49
  • GNFT 29.24
  • Support Level
  • PLBC $47.68
  • GNFT $3.63
  • Resistance Level
  • PLBC $49.27
  • GNFT $3.88
  • Average True Range (ATR)
  • PLBC 1.22
  • GNFT 0.10
  • MACD
  • PLBC -0.44
  • GNFT 0.02
  • Stochastic Oscillator
  • PLBC 65.45
  • GNFT 15.30

About PLBC Plumas Bancorp

Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: